Skip to main content
SpringerLink
Log in

The human C3b receptor

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Summary

The C3b receptor of human erythrocytes, neutrophils, monocytes, all mature B cells, a subpopulation of T cells, and glomerular podocytes is a single chain glycoprotein that exists in two allotypic forms having Mr's of approximately 250,000 (F) and 260,000 (S). The number of receptors present on erythrocytes varies by eight-fold among different individuals and is genetically regulated by two codominant alleles that are distinct from the alleles determining the structural polymorphism. The number of receptors expressed by neutrophils is subject to rapid increases from 5000 per cell to 40,000 per cell by exposure to nanomolar concentrations of C5adesArg, in vitro, and a similar mechanism is probably the basis for observing increased receptor expression on neutrophils in patients undergoing hemodialysis. Cytoskeletal association of the C3b receptor on monocytes and neutrophils is suggested by experiments demonstrating receptor-mediated phagocytosis, adsorptive endocytosis through coated pits, and restricted lateral diffusion, and by the reciprocal co-redistribution of cross-linked C3b and Fc receptors, and the detergent-insolubility of cross-linked C3b receptors. The factor H-like cofactor activity of the C3b receptor promotes the cleavage of bound C3b to iC3b, C3c and C3d, g, reactions that may enhance the clearance of circulating immune complexes and the generation of ligands for CR2 and CR3. The inherited partial deficiency of erythrocyte C3b receptors in patients with SLE, and the absence of glomerular C3b receptors in these patients with proliferative glomerulonephritis may contribute to systemic and organ-specific abnormalities in the clearance of immune complexes that contribute to the pathogenesis of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127: 1024

    Google Scholar 

  2. Abo T, Cooper MD, Balch CM (1982) Characterization of HNL-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol 129: 1752

    Google Scholar 

  3. Abrahamson DR, Fearon DT (1982) Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes. Lab Invest 48: 162

    Google Scholar 

  4. Anderson RGW, Brown MS, Goldstein JL (1977) Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts. Cell 10: 351

    Google Scholar 

  5. Arnaout MA, Melamed J, Tack BF, Colten HR (1981) Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer. J Immunol 127: 1348

    Google Scholar 

  6. Beller DI, Springer TA, Schreiber RD (1982) Anti-Mac-1 selectively inhibits mouse and human type three complement receptor. J Exp Med 156: 1000

    Google Scholar 

  7. Berger M, Gaither TA, Hammer CH, Frank MM (1981) Lack of binding of human C3, in its native state, to C3b receptors. J Immunol 127: 1329

    Google Scholar 

  8. Cornacoff JB, Hebert LA, Smead WL, VanAma ME, Birmingham DJ, Waxman FJ (1983) Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 71: 236

    Google Scholar 

  9. Dierich MP, Mussel HH, Scheiner O, Ehlen T, Burger R, Peters H, Schmitt M, Trepke S, Zimmer G (1982) Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies. Immunology 45: 85

    Google Scholar 

  10. Dobson NJ, Lambris JD, Ross GD (1981) Characteristics of isolated erythrocyte complement receptor type one (CRI, C4-C3b receptor) and CR1-specific antibodies. J Immunol 126: 693

    Google Scholar 

  11. Dykman TR, Cole JL, Iida K, Atkinson JP (1983) Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci USA 80: 1698

    Google Scholar 

  12. Fearon DT (1979) Regulation of the amplification C3 concertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 76: 5867

    Google Scholar 

  13. Fearon DT (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocytes, B lymphocyte and monocyte. J Exp Med 152: 20

    Google Scholar 

  14. Fearon DT, Kaneko I, Thomson G (1981) Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes. J Exp Med 153: 1615

    Google Scholar 

  15. Fearon DT, Collins LA (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 130: 370

    Google Scholar 

  16. Fearon DT, Wong WW (1983) Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1: 243

    Google Scholar 

  17. Frank MM, Hamburger MI, Lawley TJ, Kimberley RP, Plotz PH (1979) Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518

    Google Scholar 

  18. Gelfand MC, Shin ML, Nagle RB, Green I, Frank MM (1976) The glomerular complement receptor in immunologically mediated renal glomerular injury. N Engl J Med 295: 10

    Google Scholar 

  19. Gerdes J, Naiem M, Mason DY, Stein H (1982) Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology 45: 645

    Google Scholar 

  20. Gigli I, Nelson RA Jr (1968) Complement dependent immune phagocytosis. Esp Cell Res 51: 45

    Google Scholar 

  21. Glass D, Raum D, Gibson D, Stillman JS, Schur PH (1976) Inherited deficiency of the second component of complement. J Clin Invest 58: 853

    Google Scholar 

  22. Gordon PO, Carpentier J-L, Cohen S, Orci L (1978) Epidermal growth factor: morphological demonstration of binding, internalization and lysosomal association in human fibroblasts. Proc Natl Acad Sci USA 75: 5025

    Google Scholar 

  23. Hadding U, Hartung HP, Rasokat H, Gemsa G (1983) Peritoneal macrophages release prostaglandin E and thromboxane B2 in response to C3b. In: Normann A, Sarkin E (eds) Macrophages and NK cell function. Plenum Press, New York, in press

    Google Scholar 

  24. Hafeman DG, Smith LM, Fearon DT, McConnell HM (1982) Lipid monolayer-coated solid surfaces do not perturb the lateral motion and distribution of C3b receptors on neutrophils. J Cell Biol 94: 224

    Google Scholar 

  25. Iida K, Nussenzweig V (1981) Complement receptor is an inhibitor of the complement cascade. J Exp Med 153: 1138

    Google Scholar 

  26. Iida K, Mornaghi R, Nussenzweig V (1982) Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 155: 1427

    Google Scholar 

  27. Jack RM, Fearon DT (1983) Cytoskeletal attachment of C3b receptor (C3bR) and reciprocal coredistribution with Fc receptor (FcR) on human polymorphonuclear leukocytes (PMN). Fed Proc 42: 1235

    Google Scholar 

  28. Karp DR, Atkinson JP, Schreffler DC (1982) Genetic variation in glycosylation of the fourth component of murine complement: association with hemolytic activity. J Biol Chem 257: 7330

    Google Scholar 

  29. Kay AB, Glass EJ, Salter D McG (1979) Leukoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol 38: 294

    Google Scholar 

  30. Kazatchkine MD, Fearon DT, Appay M-D, Mandet C, Bariety J (1982) Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal disease. J Clin Invest 69: 300

    Google Scholar 

  31. Lambris JD, Cohen PL, Dobson NJ, Wheeler PW, Papamichail M, Ross GD (1982) Effect of antibodies to CR2 (C3d receptors) on lymphocyte activation. Clin Res 30: 514A

  32. Lee J, Hakim RM, Fearon DT (1983) Increased expression of C3b receptors on neutrophils induced by complement activation during hemodialysis. Clin Res 31: 492A

  33. Medicus RG, Arnaout MA (1982) Surface restricted control of C3bINA-dependent C3c release from bound C3bi molecules. Fed Proc 41: 848

    Google Scholar 

  34. Medof EM, Prince GM, Mold C (1982) Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of β1H and is accompanied by release of C3c. Proc Natl Acad Sci USA 79: 5047

    Google Scholar 

  35. Medof ME, Iidia K, Mold C, Nussenzweig V (1982) Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 156: 1739

    Google Scholar 

  36. Melamed J, Arnaout MA, Colten HR (1982) Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release. J Immunol 128: 2313

    Google Scholar 

  37. Meuth JL, Morgan EL, Hugli TE (1983) Inhibition of human T cell blastogenesis by a kallikrein cleavage fragment of iC3b. Fed Proc 42: 566

    Google Scholar 

  38. Michl J, Pieczonka MM, Unkeless JC, Silverstein SS (1979) Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycolate-elicited mouse peritoneal macrophages. J Exp Med 150: 607

    Google Scholar 

  39. Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M (1981) Defective immune adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 2: 493

    Google Scholar 

  40. Moran JE, Colasanti G, Amos N, Peters DK (1977) C3b receptors in glomerular disease. Clin Exp Immunol 28: 212

    Google Scholar 

  41. Nelson RA (1956) The immune adherence phenomenon: a hypothetical role of erythrocytes in defense against bacteria and viruses. Proc R Soc Exp Biol Med 49: 55

    Google Scholar 

  42. Newman SL, Musson RA, Henson PM (1980) Development of functional complement receptors during in vivo maturation of human monocytes into macrophages. J Immunol 125: 2236

    Google Scholar 

  43. Ortaldo JR, Sharrow O, Timonen T, Herberman RB (1981) Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 127: 2401

    Google Scholar 

  44. Perlmann HP, Perlmann RD, Schreiber RD, Muller-Eberhard HJ (1981) Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors: enhancement of antibody-mediated cellular cytotoxicity. J Exp Med 153: 1592

    Google Scholar 

  45. Petty HR, Smith LM Fearon DT, McConnell HM (1980) Lateral distribution and diffusion of the C3b receptor of complement, HLA antigens, and lipid probes in peripheral blood leukocytes. Proc Natl Acad Sci USA 77: 6587

    Google Scholar 

  46. Raum D, Awdeh Z, Yunis EJ, Alper CA (1981) Major histocompatibility markers in disease. Clin Immunol Allergy 1: 305

    Google Scholar 

  47. Ross GD, Rabellino EM, Polley MJ, Grey HM (1973) Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest 52: 377

    Google Scholar 

  48. Ross GD, Winchester RJ, Rabellino EM, Hoffman T (1978) Surface markers of complement receptor lymphocytes. J Clin Invest 62: 1086

    Google Scholar 

  49. Ross GD, Lambris JD, Cain JA, Newman SL (1982) Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H versus CR1 cofactor activity. J Immunol 129: 2051

    Google Scholar 

  50. Sim E, Sim RB (1983) Enzymatic assay of C3b receptor on intact cells and solubilized cells. Biochem J, in press

  51. Sobel AT, Gabay YE, Lagrue G (1976) Analysis of glomerular complement receptors in various types of glomerulonephritis. Clin Immunol Immunopathol 6: 94

    Google Scholar 

  52. Tedder TF, Fearon DT, Gartland GL, Cooper MD (1983) Expression of C3b receptors on human B cells and myelomonocytic cells but not natural killer cells. J Immunol 130: 1668

    Google Scholar 

  53. Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153: 569

    Google Scholar 

  54. Van de Griend RJ, Berge IT, Tanke HJ, Roos D, Schellekens PTA, Melief CJM, Zeijlemaker WP, Astaldi A (1982) Characterization of two subsets of human T cells. J Immunol 128: 1979

    Google Scholar 

  55. Willingham MC, Maxfield FR, Pastan IH (1979) α2 Macroglobulin binding to the plasma membrane of cultured fibroblasts: diffuse binding followed by clustering in coated regions. J Cell Biol 82: 614

    Google Scholar 

  56. Wilson JG, Wong WW, Schur PH, Fearon DT (1982) Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 307: 981

    Google Scholar 

  57. Wilson JG, Tedder TF, Fearon DT (1983) Characterization of human T lymphocytes that express the C3b receptor. J Immunol, in press

  58. Wong W, Wilson J, Fearon DT (1983) Genetic regulation of a structural polymorphism of human C3b receptor. J Clin Invest, in press

  59. Wright SD, Silverstein SC (1982) Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J Exp Med 156: 1149

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Harvard Medical School, USA

    Douglas T. Fearon

  2. Department of Rheumatology and Immunology, Brigham and Women's Hospital, 02115, Boston, MA, USA

    Douglas T. Fearon

Authors
  1. Douglas T. Fearon
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by grants AI-17917, AI-07722, AI-10356, and AM-05577 from the National Institutes of Health

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fearon, D.T. The human C3b receptor. Springer Semin Immunopathol 6, 159–172 (1983). https://doi.org/10.1007/BF00205871

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205871

Keywords

Search

Navigation